| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/21/2004 | WO2004042054A1 Genetic morphisms relating to periodontal diseases |
| 05/21/2004 | WO2004042049A1 Method of degrading hardly degradable protein |
| 05/21/2004 | WO2004042046A2 Effective and stable dna enzymes |
| 05/21/2004 | WO2004042036A2 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii |
| 05/21/2004 | WO2004042034A2 Method for the linear amplification of complementary dna |
| 05/21/2004 | WO2004042029A2 Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use |
| 05/21/2004 | WO2004042027A2 Allele-specific rna interference |
| 05/21/2004 | WO2004042025A2 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 05/21/2004 | WO2004042024A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA |
| 05/21/2004 | WO2004042023A2 Stem cell libraries |
| 05/21/2004 | WO2004042015A2 Methods and vectors for controlling gene expression |
| 05/21/2004 | WO2004042007A2 Somatic cell gene targeting vectors and methods of use thereof |
| 05/21/2004 | WO2004042004A2 Mouse model for autoimmune disorders |
| 05/21/2004 | WO2004042002A2 Compounds for modulating rna interference |
| 05/21/2004 | WO2004041999A2 No-apical meristem proteins, polynucleotides and methods of use for same |
| 05/21/2004 | WO2004041924A2 Non-phosphorous-linked oligomeric compounds and their use in gene modulation |
| 05/21/2004 | WO2004041889A2 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/21/2004 | WO2004041867A2 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | WO2004041865A2 Stabilized single domain antibodies |
| 05/21/2004 | WO2004041863A2 Single domain antibodies directed against interferon- gamma and uses therefor |
| 05/21/2004 | WO2004041862A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | WO2004041860A1 Icam-4 binding sites |
| 05/21/2004 | WO2004041859A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | WO2004041857A2 Mutant of clostridium difficile toxin b and methods of use |
| 05/21/2004 | WO2004041856A2 Crystal structures of bacterial inorganic pyrophosphatases |
| 05/21/2004 | WO2004041855A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 05/21/2004 | WO2004041854A2 Essential novel bacterial polypeptides |
| 05/21/2004 | WO2004041851A2 Vaccine |
| 05/21/2004 | WO2004041841A2 Molecular identification of bacteria of genus streptococcus and related genuses |
| 05/21/2004 | WO2004041838A1 Regulation of transcription elongation factors |
| 05/21/2004 | WO2004041304A2 Pain relief agents |
| 05/21/2004 | WO2004041213A2 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 05/21/2004 | WO2004041212A2 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | WO2004041197A2 Methods of inhibiting glial scar formation |
| 05/21/2004 | WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5 |
| 05/21/2004 | WO2004041183A2 Methods of treating pulmonary fibrotic disorders |
| 05/21/2004 | WO2004041177A2 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 05/21/2004 | WO2004041170A2 Compositions and methods for the treatment of immune related diseases |
| 05/21/2004 | WO2004041065A2 METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS |
| 05/21/2004 | WO2004040976A1 Cryogenically protected viral delivery systems and related manufacture and use |
| 05/21/2004 | WO2004040973A2 Organellar targeting of rna and its use in the interruption of environmental gene flow |
| 05/21/2004 | WO2004040971A1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 05/21/2004 | WO2004040970A1 Model animal of human hematopoietic organ tumor |
| 05/21/2004 | WO2004040969A1 Transgenic mammal carrying ganp and utilization thereof |
| 05/21/2004 | WO2004035782A3 Sirna mediated gene silencing in transgenic animals |
| 05/21/2004 | WO2004031353A9 Apparatus and method for streaming electroporation |
| 05/21/2004 | WO2004031351A9 Microarrays having multiple oligonucleotides in single array features |
| 05/21/2004 | WO2004027066A3 Chimeric recombinant protein and in vitro diagnosis of hiv |
| 05/21/2004 | WO2004024925A8 Collectin-complement activating protein chimeras |
| 05/21/2004 | WO2004024867A3 Vigilant vector system |
| 05/21/2004 | WO2004023092A3 Genetic analysis and authentication |
| 05/21/2004 | WO2004022738A8 Methods and compositions for the generation of humanized mice |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004020630A3 Method for gene isolation by cre-trap cloning |
| 05/21/2004 | WO2004018685A3 Active fusion proteins and method for the production thereof |
| 05/21/2004 | WO2004016652A3 Mammaglobin promoter |
| 05/21/2004 | WO2004013610A3 Method of measuring molecular interactions |
| 05/21/2004 | WO2004009843A3 Detection of microorganisms |
| 05/21/2004 | WO2004009824A3 Pav regions for encapsidation and e1 transcriptioonal control |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2004009541A3 Antisense modulation of endothelial lipase expression |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2004003153A9 Live replicating spumavirus vector |
| 05/21/2004 | WO2004001506A3 Antireflective coatings for high-resolution photolithographic synthesis of dna array |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003102215A3 Methods of identifying and isolating stem cells and cancer stem cells |
| 05/21/2004 | WO2003102190A3 Bacterial polypeptides involved in viability |
| 05/21/2004 | WO2003093440A3 Methods and compositions for expressing a nucleic acid in a dendritic cell |
| 05/21/2004 | WO2003089462A3 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/21/2004 | WO2003085110A3 Oligomeric compounds for the modulation hif-1alpha expression |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003066650A3 Short interfering rna molecules directed towards a tissue factor coding nucleic acid |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003053135A9 Plant xrcc3 genes and methods of use |
| 05/21/2004 | WO2003050249B1 Islet cells from human embryonic stem cells |
| 05/21/2004 | WO2003049766A8 Method of purifying hepatitis a virus particles and vaccine preparation |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2003013422A3 Methods for the treatment and prognosis of leukemia and other cancer types |
| 05/21/2004 | WO2003006660A8 Expression cassettes for the transgenic expression of nucleic acids |
| 05/21/2004 | WO2003004684A3 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
| 05/21/2004 | WO2003000114A9 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 05/21/2004 | WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 05/21/2004 | WO2002096923B1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 05/21/2004 | WO2002095014A9 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 05/21/2004 | WO2002083869A9 Product and process for transformation of thraustochytriales microorganisms |
| 05/21/2004 | WO2002081490A8 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 05/21/2004 | WO2002063025A8 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002058724A8 Use of lp82 to treat body weight disorders |
| 05/21/2004 | WO2002040674A9 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2001066690A3 Novel compounds |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2545304A1 Method of immobilising a protein to a zeolite |
| 05/21/2004 | CA2506654A1 Method of detecting gene mutation |